Astec Lifesciences Ltd: Latest news and updates on Astec Lifesciences .

Astec Lifesciences Ltd

News

Switch to

Astec Lifesciences Ltd

ASTEC

387.156.70 (+1.76%)

Investment Checklist

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Current price is less than the intrinsic value

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Stock has been generating better return on equity than bank FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Stock doesn't offer attractive dividend returns

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

Good time to consider, as stock is not in overbought zone

No Red Flags
ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list, with high pledged promoter holding or high default probability should be handled with caution

Stock not in ASM/GSM lists, not a lot of promoter holding is pledged and default probability is low

Overview Forecasts Financials Peers Holdings News Events

News & Opinions

Latest

No latest news available

Older

What to Watch: Maruti, Vodafone, Vedanta results eyed

4 months ago•The Hindu Businessline

Godrej Agrovet-Astec merger ratio is 11:10

1 year ago•The Hindu Businessline

Astec Lifesciences gains 12% on merger of Co with Godrej Agrovet

1 year ago•Moneycontrol

Tata Global, RInfra, Jindal Saw results

1 year ago•The Hindu Businessline

Alpha Ideas 20-20: Acepro Advisors’ Kunj Bansal Bets On Astec Lifesciences. Here’s Why

1 year ago•Bloomberg Quint

Jyothy Labs, TAKE Solutions, Tata Elxsi hit new high

1 year ago•Business Standard